Farmako ApS: Financial statements 2019
CVR: 40143548
Source: annual report 2019, Danish Business Authority
07/01/2019 – 31/12/2019
Farmako ApS (CVR 40143548) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -28,970 and a net result of DKK -28,974. Equity in the 2019 report amounted to DKK 21,026. The solvency ratio was 62.7%.
- Gross Profit
- DKK -28,970
- Profit/Loss
- DKK -28,974
- Equity
- DKK 21,026
- Total Assets
- DKK 33,527
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of July 4, 2019, Andreas Karl Matthias Jägle is registered as director of Farmako ApS.
As of July 4, 2019, Anna-Sophia Kouparanis has stepped down as director of Farmako ApS.
As of January 7, 2019, Anna-Sophia Kouparanis is registered as director of Farmako ApS.
Farmako ApS was founded on January 7, 2019.
About Farmako ApS
Farmako ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2019. The company has been dissolved on 19 June 2026. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2024, the company reported a gross profit of DKK -15,750 and a net result of DKK -15,749 compared with DKK -16,875 the year before. Equity in the 2024 report amounted to DKK -65,153.